Critical Care

official impact factor 4.60

Open Access

Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study

Helena Brodska, Tomas Drabek, Karin Malickova, Antonin Kazda, Antonin Vitek, Tomas Zima and Marketa Markova*

Critical Care 2009, 13:R37 doi:10.1186/cc7749


See related commentary by McLean, http://ccforum.com/content/13/3/149

Accesses  

  • Last 30 days: 40 accesses
  • Last 365 days: 632 accesses
  • All time: 3046 accesses

Cited by